Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
81 participants
OBSERVATIONAL
2011-12-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to describe in detail the cases with telomerase mutation in terms of features on CT scan, respiratory function and evolution, in comparison to control subjects with idiopathic pulmonary fibrosis and no telomerase mutation identified or family history.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis
NCT05895409
Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
NCT00212511
Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis
NCT02594059
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
NCT00258570
Genetics of the Combined Pulmonary Fibrosis and Emphysema Syndrome
NCT02439528
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The data are all the results of investigations conducted for the diagnosis of idiopathic pulmonary fibrosis and during routine follow up of patients.
The CT scans will reviewed centrally to homogenize the description.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
telomerase mutation
Patients with interstitial lung disease and telomerase mutation
No interventions assigned to this group
control
Patients with idiopathic pulmonary fibrosis and without telomerase mutation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Telomerase mutation analysis
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bichat Hospital
OTHER
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vincent COTTIN
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
vincent Cottin, MD
Role: PRINCIPAL_INVESTIGATOR
Hospices civils de Lyon / University Lyon I
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Louis Pradel Hospital (Bâtiment A4)
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
website National French Reference Center for rare lung diseases
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GERMOP-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.